Glucose intolerance: Difference between revisions

Jump to navigation Jump to search
 
Line 21: Line 21:
*[[Medroxyprogesterone acetate]]
*[[Medroxyprogesterone acetate]]
*[[Megestrol]]
*[[Megestrol]]
*[[Pegaspargase]]


==Treatment==
==Treatment==

Latest revision as of 14:42, 17 February 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

WikiDoc Resources for Glucose intolerance

Articles

Most recent articles on Glucose intolerance

Most cited articles on Glucose intolerance

Review articles on Glucose intolerance

Articles on Glucose intolerance in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Glucose intolerance

Images of Glucose intolerance

Photos of Glucose intolerance

Podcasts & MP3s on Glucose intolerance

Videos on Glucose intolerance

Evidence Based Medicine

Cochrane Collaboration on Glucose intolerance

Bandolier on Glucose intolerance

TRIP on Glucose intolerance

Clinical Trials

Ongoing Trials on Glucose intolerance at Clinical Trials.gov

Trial results on Glucose intolerance

Clinical Trials on Glucose intolerance at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Glucose intolerance

NICE Guidance on Glucose intolerance

NHS PRODIGY Guidance

FDA on Glucose intolerance

CDC on Glucose intolerance

Books

Books on Glucose intolerance

News

Glucose intolerance in the news

Be alerted to news on Glucose intolerance

News trends on Glucose intolerance

Commentary

Blogs on Glucose intolerance

Definitions

Definitions of Glucose intolerance

Patient Resources / Community

Patient resources on Glucose intolerance

Discussion groups on Glucose intolerance

Patient Handouts on Glucose intolerance

Directions to Hospitals Treating Glucose intolerance

Risk calculators and risk factors for Glucose intolerance

Healthcare Provider Resources

Symptoms of Glucose intolerance

Causes & Risk Factors for Glucose intolerance

Diagnostic studies for Glucose intolerance

Treatment of Glucose intolerance

Continuing Medical Education (CME)

CME Programs on Glucose intolerance

International

Glucose intolerance en Espanol

Glucose intolerance en Francais

Business

Glucose intolerance in the Marketplace

Patents on Glucose intolerance

Experimental / Informatics

List of terms related to Glucose intolerance

Synonyms and keywords: Glucose intolerance; impaired glucose intolerance; impaired glycemia

Overview

Impaired Glucose Tolerance (IGT) is a pre-diabetic state of dysglycemia, that is associated with insulin resistance and increased risk of cardiovascular pathology. IGT may precede type 2 diabetes mellitus by many years. IGT is also a risk factor for mortality.

Criteria

According to the criteria of the World Health Organization and the American Diabetes Association, impaired glucose tolerance is defined as:

  • two-hour glucose levels of 140 to 199 mg per dL (7.8 to 11.0 mmol) on the 75-g oral glucose tolerance test. A patient is said to be under the condition of IGT when he/she has an intermediately raised glucose level after 2 hours, but less than would qualify for type 2 diabetes mellitus. The fasting glucose may be either normal or mildly elevated.

From 10 to 15 percent of adults in the United States have one of these conditions.

Causes

Drug Side Efect

Treatment

The risk of progression to diabetes and development of cardiovascular disease is greater than for Impaired fasting glycaemia.

Although some drugs can delay the onset of diabetes, lifestyle modifications play a greater role in the prevention of the disease. Patients identified as having an IGT should exercise regularly and have a balanced diet removing the empty calories of sugar.

Carnitine has been shown to improve glucose uptake, regulation, and oxidation, though temporarily (i.e. only when levels are sustained in the blood).

References

Template:WH Template:WikiDoc Sources